-
1
-
-
0001744038
-
Malignant germ cell tumors of ovary: Clinical features and management
-
Coppleson M (ed). Edinburgh, Churchill Livingstone
-
1. Gershenson DM: Malignant germ cell tumors of ovary: clinical features and management, in Coppleson M (ed): Gynecologic Oncology. Edinburgh, Churchill Livingstone, 1992, Vol 2, pp 935-945
-
(1992)
Gynecologic Oncology
, vol.2
, pp. 935-945
-
-
Gershenson, D.M.1
-
2
-
-
0000618792
-
Pathology of malignant germ cell tumors of ovary
-
Coppleson, M (ed). Edinburgh, Churchill Livingstone
-
2. Norris HJ, O'Connor DM: Pathology of malignant germ cell tumors of ovary, in Coppleson, M (ed): Gynecologic Oncology. Edinburgh, Churchill Livingstone, 1992, Vol 2, pp 917-934
-
(1992)
Gynecologic Oncology
, vol.2
, pp. 917-934
-
-
Norris, H.J.1
O'Connor, D.M.2
-
3
-
-
0024455195
-
Inhibin as a marker for granulosa-cell tumors
-
3. Lappöhn RE, Burger HG, Bouma J, Bangah M, Krans M, deBruijn HWA: Inhibin as a marker for granulosa-cell tumors. N Engl J Med 321:790-793, 1989
-
(1989)
N Engl J Med
, vol.321
, pp. 790-793
-
-
Lappöhn, R.E.1
Burger, H.G.2
Bouma, J.3
Bangah, M.4
Krans, M.5
DeBruijn, H.W.A.6
-
4
-
-
0027056896
-
GnRH agonist analog therapy in advanced/recurrent granulosa cell tumors: Further evidence of a role of inhibin in monitoring response to treatment
-
4. Kauppila A, Bangah M, Burger H, Martikainen H: GnRH agonist analog therapy in advanced/recurrent granulosa cell tumors: further evidence of a role of inhibin in monitoring response to treatment. Gynecol Endocrinol 6:271-274, 1992
-
(1992)
Gynecol Endocrinol
, vol.6
, pp. 271-274
-
-
Kauppila, A.1
Bangah, M.2
Burger, H.3
Martikainen, H.4
-
5
-
-
0027382383
-
Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors
-
5. Healy DL, Burger HG, Mamers P, Jobling T, Bangah M, Quinn M, Grant P, Day AJ, Rome R, Campbell JJ: Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Engl J Med 329:1539-1542, 1993
-
(1993)
N Engl J Med
, vol.329
, pp. 1539-1542
-
-
Healy, D.L.1
Burger, H.G.2
Mamers, P.3
Jobling, T.4
Bangah, M.5
Quinn, M.6
Grant, P.7
Day, A.J.8
Rome, R.9
Campbell, J.J.10
-
6
-
-
0028134976
-
A prospective study of inhibin in granulosa cell tumors of the ovary
-
6. Jobling T, Mamers P, Healy DL, MacLachlan V, Burger HG, Quinn M, Rome R, Day AJ: A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol Oncol 55:285-289, 1994
-
(1994)
Gynecol Oncol
, vol.55
, pp. 285-289
-
-
Jobling, T.1
Mamers, P.2
Healy, D.L.3
MacLachlan, V.4
Burger, H.G.5
Quinn, M.6
Rome, R.7
Day, A.J.8
-
7
-
-
0031030632
-
Serum inhibin and disease status in women with ovarian granulosa cell tumors
-
7. Boggess JF, Soules MR, Goff BA, Greer BE, Cain JM, Tamimi HK: Serum inhibin and disease status in women with ovarian granulosa cell tumors. Gynecol Oncol 64:64-69, 1997
-
(1997)
Gynecol Oncol
, vol.64
, pp. 64-69
-
-
Boggess, J.F.1
Soules, M.R.2
Goff, B.A.3
Greer, B.E.4
Cain, J.M.5
Tamimi, H.K.6
-
8
-
-
0029549319
-
Tumor-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in patients with epithelial ovarian cancer
-
8. Peters-Engl C, Medl M, Ogris E, Leodolter S: Tumor-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in patients with epithelial ovarian cancer. Anticancer Res 15(6B):2727-2730, 1995
-
(1995)
Anticancer Res
, vol.15
, Issue.6 B
, pp. 2727-2730
-
-
Peters-Engl, C.1
Medl, M.2
Ogris, E.3
Leodolter, S.4
-
9
-
-
0029944551
-
Measurement of dimeric inhibin B throughout the human menstrual cycle
-
9. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather J, McNeilly AS: Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 81:1400-1405, 1996
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 1400-1405
-
-
Groome, N.P.1
Illingworth, P.J.2
O'Brien, M.3
Pai, R.4
Rodger, F.E.5
Mather, J.6
McNeilly, A.S.7
-
10
-
-
0019990985
-
Immunochemical demonstration of an ovarian cancer-associated urinary peptide
-
10. Stenman U-H, Huhtala M-L, Koistinen R, Seppälä, M: Immunochemical demonstration of an ovarian cancer-associated urinary peptide. Int J Cancer 30:53-57, 1982
-
(1982)
Int J Cancer
, vol.30
, pp. 53-57
-
-
Stenman, U.-H.1
Huhtala, M.-L.2
Koistinen, R.3
Seppälä, M.4
-
11
-
-
0026549699
-
Serum lactic dehydrogenase as a tumor marker in dysgerminoma
-
11. Pressley RH, Muntz HG, Falkenberry S, Rice LW: Serum lactic dehydrogenase as a tumor marker in dysgerminoma. Gynecol Oncol 44:281-283, 1992
-
(1992)
Gynecol Oncol
, vol.44
, pp. 281-283
-
-
Pressley, R.H.1
Muntz, H.G.2
Falkenberry, S.3
Rice, L.W.4
-
12
-
-
0027245064
-
Does inhibin have an endocrine function during the menstrual cycle?
-
12. Fraser HM, Lunn SF: Does inhibin have an endocrine function during the menstrual cycle? Trend Endocrinol Metab 4:187-194, 1993
-
(1993)
Trend Endocrinol Metab
, vol.4
, pp. 187-194
-
-
Fraser, H.M.1
Lunn, S.F.2
-
13
-
-
0025605635
-
Inhibin and activin locally regulate rat ovarian folliculogenesis
-
13. Woodruff TK, Lyon RJ, Hansen SE, Rice GC, Mather JP: Inhibin and activin locally regulate rat ovarian folliculogenesis. Endocrinology 127: 3196-3205, 1990
-
(1990)
Endocrinology
, vol.127
, pp. 3196-3205
-
-
Woodruff, T.K.1
Lyon, R.J.2
Hansen, S.E.3
Rice, G.C.4
Mather, J.P.5
-
14
-
-
0020565927
-
Excretion of a tumor-associated trypsin inhibitor (TATI) in urine of patients with gynecological malignancy
-
14. Huhtala M-L, Kahanpää K, Seppälä M, Halila H, Stenman U-H: Excretion of a tumor-associated trypsin inhibitor (TATI) in urine of patients with gynecological malignancy. Int J Cancer 31:711-714, 1983
-
(1983)
Int J Cancer
, vol.31
, pp. 711-714
-
-
Huhtala, M.-L.1
Kahanpää, K.2
Seppälä, M.3
Halila, H.4
Stenman, U.-H.5
-
15
-
-
0023887432
-
Tumour-associated trypsin inhibitor (TATI) in ovarian cancer
-
15. Halila H, Lehtovirta P, Stenman U-H: Tumour-associated trypsin inhibitor (TATI) in ovarian cancer. Br J Cancer 57:304-307, 1988
-
(1988)
Br J Cancer
, vol.57
, pp. 304-307
-
-
Halila, H.1
Lehtovirta, P.2
Stenman, U.-H.3
-
16
-
-
0029923588
-
Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours
-
16. Burger HG, Robertson DM, Cahir N, Mamers P, Healy DL, Jobling T, Groome N: Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours. Clin Endocrinol 44:413-418, 1996
-
(1996)
Clin Endocrinol
, vol.44
, pp. 413-418
-
-
Burger, H.G.1
Robertson, D.M.2
Cahir, N.3
Mamers, P.4
Healy, D.L.5
Jobling, T.6
Groome, N.7
|